Trevi Therapeutics, Inc. · NASDAQ:TRVI
Venrock Healthcare Capital Partners II, L.P.'s stake in Trevi Therapeutics, Inc. fell to 1.40% (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 14, 2025
Venrock Healthcare Capital Partners II, L.P.'s stake in Trevi Therapeutics, Inc. fell to 1.40%, 1,266,457 shares, as a passive investor on Dec 31, 2024. Filed Feb 14, 2025 (Schedule 13G/A).
- Stake
- 1.40%
- Shares
- 1,266,457
- Intent
- Passive
- What changed
- Fell below 5%
- Filed together
- 10 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Venrock Healthcare Capital Partners II, L.P. | 1.40% | 1,266,457 |
| VHCP Co-Investment Holdings II, LLC | 1.40% | 1,266,457 |
| VHCP Management II, LLC | 1.40% | 1,266,457 |
| Venrock Healthcare Capital Partners III, L.P. | 1.40% | 1,266,457 |
| VHCP Co-Investment Holdings III, LLC | 1.40% | 1,266,457 |
| Venrock Healthcare Capital Partners EG, L.P. | 1.40% | 1,266,457 |
| VHCP Management III, LLC | 1.40% | 1,266,457 |
| VHCP Management EG, LLC | 1.40% | 1,266,457 |
| Nimish Shah | 1.40% | 1,266,457 |
| Bong Y Koh | 1.40% | 1,266,457 |
Source
Related
- Trevi Therapeutics, Inc.
- Venrock Healthcare Capital Partners II, L.P.
- Trevi Therapeutics, Inc. shareholders
- Form 4 · Heffernan Michael Thomas · Sep 17, 2026
- Schedule 13G/A · FMR LLC · Aug 6, 2026
- Schedule 13D/A · New Enterprise Associates 16, L.P. · May 7, 2026
- Schedule 13G/A · FMR LLC · May 6, 2026
- Schedule 13G/A · The Vanguard Group · Mar 27, 2026